Literature DB >> 18350359

"Pseudodominant inheritance" of ataxia with ocular apraxia type 2 (AOA2).

Ludger Schöls1, Larissa Arning, Rebecca Schüle, Jörg T Epplen, Dagmar Timmann.   

Abstract

Ataxia with ocular apraxia type 2 (AOA2) is an autosomal recessive, early onset ataxia caused by mutations in the senataxin (SETX) gene. Ocular apraxia and increased levels of alpha-fetoprotein are characteristic but not obligate markers of the disease. AOA2 is allelic with ALS4, a motor neuron disorder of early onset and autosomal dominant inheritance. We observed a two generation family with ataxia which started at age 14 and 17 in two sibs and at age 23 in their paternal uncle.Oculomotor disturbances included strabismus, saccadic pursuit and gaze evoked nystagmus. MRI revealed severe cerebellar atrophy. All patients presented pronounced peripheral neuropathy with wasting of hand and leg muscles resembling distal motor neuronopathy. Increased alphafetoprotein levels triggered genetic analyses of SETX. We found the sib pair to be compound heterozygous for a single base deletion c.2835delC, resulting in a frameshift mutation and causing nonsense related mRNA decay, and a base exchange c.6106G > A, resulting in abnormal splicing and skipping of exon 15. The similarly affected uncle was homozygous for the c.6106G > A mutation probably due to distant consanguinity in the paternal branch of the family. Pseudodominant occurrence in two generations has not been described before in AOA2 and led, in this family, to false categorization as dominant ataxia before SETX mutations were detected. Clinically this family presented with a phenotype combining typical features of AOA2 and ALS4; thus extending the phenotypic spectrum of SETX mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350359     DOI: 10.1007/s00415-008-0707-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.

Authors:  C Criscuolo; L Chessa; S Di Giandomenico; P Mancini; F Saccà; G S Grieco; M Piane; F Barbieri; G De Michele; S Banfi; F Pierelli; N Rizzuto; F M Santorelli; L Gallosti; A Filla; C Casali
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

2.  Autosomal dominant sensory/motor neuropathy with Ataxia (SMNA): Linkage to chromosome 7q22-q32.

Authors:  Zoran Brkanac; Magali Fernandez; Mark Matsushita; Hilary Lipe; John Wolff; Thomas D Bird; Wendy H Raskind
Journal:  Am J Med Genet       Date:  2002-05-08

3.  Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34.

Authors:  P F Chance; B A Rabin; S G Ryan; Y Ding; M Scavina; B Crain; J W Griffin; D R Cornblath
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

4.  Friedreich's ataxia. Revision of the phenotype according to molecular genetics.

Authors:  L Schöls; G Amoiridis; H Przuntek; G Frank; J T Epplen; C Epplen
Journal:  Brain       Date:  1997-12       Impact factor: 13.501

5.  Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1.

Authors:  K Flanigan; K Gardner; K Alderson; B Galster; B Otterud; M F Leppert; C Kaplan; L J Ptácek
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

6.  Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX.

Authors:  T Asaka; H Yokoji; J Ito; K Yamaguchi; A Matsushima
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

7.  Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder?

Authors:  P De Jonghe; M Auer-Grumbach; J Irobi; K Wagner; B Plecko; M Kennerson; D Zhu; E De Vriendt; V Van Gerwen; G Nicholson; H-P Hartung; V Timmerman
Journal:  Brain       Date:  2002-06       Impact factor: 13.501

8.  Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder.

Authors:  Marie Fernet; Moez Gribaa; Mustafa A M Salih; Mohamed Zein Seidahmed; Janet Hall; Michel Koenig
Journal:  Hum Mol Genet       Date:  2004-12-01       Impact factor: 6.150

9.  Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients.

Authors:  Isabelle Le Ber; Naïma Bouslam; Sophie Rivaud-Péchoux; João Guimarães; Ali Benomar; Céline Chamayou; Cyril Goizet; Maria-Ceù Moreira; Sandra Klur; Mohamed Yahyaoui; Yves Agid; Michel Koenig; Giovanni Stevanin; Alexis Brice; Alexandra Dürr
Journal:  Brain       Date:  2004-01-21       Impact factor: 13.501

10.  Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.

Authors:  Maria-Céu Moreira; Sandra Klur; Mitsunori Watanabe; Andrea H Németh; Isabelle Le Ber; José-Carlos Moniz; Christine Tranchant; Patrick Aubourg; Meriem Tazir; Lüdger Schöls; Massimo Pandolfo; Jörg B Schulz; Jean Pouget; Patrick Calvas; Masami Shizuka-Ikeda; Mikio Shoji; Makoto Tanaka; Louise Izatt; Christopher E Shaw; Abderrahim M'Zahem; Eimear Dunne; Pascale Bomont; Traki Benhassine; Naïma Bouslam; Giovanni Stevanin; Alexis Brice; João Guimarães; Pedro Mendonça; Clara Barbot; Paula Coutinho; Jorge Sequeiros; Alexandra Dürr; Jean-Marie Warter; Michel Koenig
Journal:  Nat Genet       Date:  2004-02-08       Impact factor: 38.330

View more
  15 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

Review 2.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

3.  Pitfalls in ataxia with ocular motor apraxia type 1: pseudodominant inheritance and very late onset.

Authors:  Chloé Laurencin; Mathieu Anheim; Lise Larrieu; Caroline Tilikete; Michel Koenig; Stéphane Thobois
Journal:  J Neurol       Date:  2015-04-07       Impact factor: 4.849

4.  (1)H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2.

Authors:  Isabelle Iltis; Diane Hutter; Khalaf O Bushara; H Brent Clark; Myron Gross; Lynn E Eberly; Christopher M Gomez; Gülin Oz
Journal:  Brain Res       Date:  2010-08-14       Impact factor: 3.252

5.  Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin.

Authors:  Giovanni Airoldi; Andrea Guidarelli; Orazio Cantoni; Chris Panzeri; Chiara Vantaggiato; Sara Bonato; Maria Grazia D'Angelo; Sestina Falcone; Clara De Palma; Alessandra Tonelli; Claudia Crimella; Sara Bondioni; Nereo Bresolin; Emilio Clementi; Maria Teresa Bassi
Journal:  Neurogenetics       Date:  2009-07-11       Impact factor: 2.660

6.  EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.

Authors:  M Filippi; F Agosta; S Abrahams; F Fazekas; J Grosskreutz; S Kalra; J Kassubek; V Silani; M R Turner; J C Masdeu
Journal:  Eur J Neurol       Date:  2010-02-02       Impact factor: 6.089

7.  Identification and characterisation of a large senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).

Authors:  Larissa Arning; Ludger Schöls; Huriye Cin; Manfred Souquet; Jörg T Epplen; Dagmar Timmann
Journal:  Neurogenetics       Date:  2008-07-29       Impact factor: 2.660

8.  Ataxia oculomotor apraxia type 2: course over 27 years and a novel stop mutation in the senataxin gene.

Authors:  Tobias Haack; Douglas Friday; Andreas Bender; Arndt Rolfs; Thomas Klopstock
Journal:  J Neurol       Date:  2009-04-18       Impact factor: 4.849

9.  Evidence of synergism among three genetic variants in a patient with LMNA-related lipodystrophy and amyotrophic lateral sclerosis leading to a remarkable nuclear phenotype.

Authors:  Kathryn Volkening; Sali M K Farhan; Jessica Kao; Cheryl Leystra-Lantz; Lee Cyn Ang; Adam McIntyre; Jian Wang; Robert A Hegele; Michael J Strong
Journal:  Mol Cell Biochem       Date:  2021-03-04       Impact factor: 3.396

10.  Aberrant splicing of the senataxin gene in a patient with ataxia with oculomotor apraxia type 2.

Authors:  Brent L Fogel; Ji Yong Lee; Susan Perlman
Journal:  Cerebellum       Date:  2009-12       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.